These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 31479402)

  • 1. Physical Activity Indicators, Metabolic Biomarkers, and Comorbidity in Type 2 Diabetes.
    Akinci B; Yeldan I; Celik S; Satman I
    Res Q Exerc Sport; 2019 Dec; 90(4):690-698. PubMed ID: 31479402
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of insulin with or without continuation of oral hypoglycemic agents in the treatment of secondary failure in NIDDM patients.
    Chow CC; Tsang LW; Sorensen JP; Cockram CS
    Diabetes Care; 1995 Mar; 18(3):307-14. PubMed ID: 7555472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Study of Effects of Pioglitazone and Rosiglitazone on Various Parameters in Patients of Type-2 Diabetes Mellitus with Special Reference to Lipid Profile.
    Sharma SK; Verma SH
    J Assoc Physicians India; 2016 Sep; 64(9):24-28. PubMed ID: 27762511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [INERTIA study: Clinical inertia in non-insulinized patients on oral hypoglycemic treatment. A study in Spanish primary and specialty care settings].
    González-Clemente JM; Font B; Lahoz R; Llauradó G; Gambús G;
    Med Clin (Barc); 2014 Jun; 142(11):478-84. PubMed ID: 23622897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased complications in noninsulin-dependent diabetic patients treated with insulin versus oral hypoglycemic agents: a population study.
    Savage S; Estacio RO; Jeffers B; Schrier RW
    Proc Assoc Am Physicians; 1997 Mar; 109(2):181-9. PubMed ID: 9069587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complementary insulin therapy improves blood glucose and serum lipid parameters in type 2 (non-insulin-dependent) diabetic patients. II. Effects on serum lipids, lipoproteins and apoproteins.
    Vaverková H; Chlup R; Ficker L; Novotny D; Bartek J
    Exp Clin Endocrinol Diabetes; 1997; 105 Suppl 2():74-7. PubMed ID: 9288551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Identification of factors predicting early evolution of secondary oral hypoglycaemic agent failure and evaluation of clinical standards applied by primary care physicians during qualification to insulin therapy of patients with type 2 diabetes].
    Machoy M
    Ann Acad Med Stetin; 2004; 50(2):29-39. PubMed ID: 16529163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baseline and 1-year interim follow-up assessment of Japanese patients initiating insulin therapy who were enrolled in the cardiovascular risk evaluation in people with type 2 diabetes on insulin therapy study: an international, multicenter, observational study.
    Kawamori R; Node K; Hanafusa T; Atsumi Y; Naito Y; Oka Y
    Cardiovasc Diabetol; 2013 Sep; 12():131. PubMed ID: 24011395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhaled insulin provides improved glycemic control in patients with type 2 diabetes mellitus inadequately controlled with oral agents: a randomized controlled trial.
    Weiss SR; Cheng SL; Kourides IA; Gelfand RA; Landschulz WH;
    Arch Intern Med; 2003 Oct; 163(19):2277-82. PubMed ID: 14581245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes of the glycemic control and therapeutic regimen for diabetes mellitus in the Japanese patients on hemodialysis.
    Sanai T; Tada H; Ono T; Fukumitsu T
    Diabetes Metab Syndr; 2015; 9(4):244-6. PubMed ID: 25866098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical effectiveness of Novolin® 30R versus Lantus® combined with Glucobay® treatment in elderly patients with type 2 diabetes mellitus controlled by oral hypoglycaemic agents: A randomized study.
    Sun Y; Shao L; Niu X; Liu Y; Ge J; Jiang H; Zhang H
    J Int Med Res; 2014 Aug; 42(4):993-1001. PubMed ID: 24925584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parameters measuring beta-cell function are only valuable in diabetic subjects with low body mass index, high blood glucose level, or long-standing diabetes.
    Lee SW; Lee S; Kim SH; Kim TH; Kang BS; Yoo SH; Lee MK; Koh WJ; Kang WS; Kim HJ
    Yonsei Med J; 2011 Nov; 52(6):939-47. PubMed ID: 22028157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of regular physical activity on blood glucose control and cardiovascular risk factors in adolescents with type 2 diabetes mellitus--a multicenter study of 578 patients from 225 centres.
    Herbst A; Kapellen T; Schober E; Graf C; Meissner T; Holl RW;
    Pediatr Diabetes; 2015 May; 16(3):204-10. PubMed ID: 24888254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycemic variability correlates strongly with postprandial beta-cell dysfunction in a segment of type 2 diabetic patients using oral hypoglycemic agents.
    Kohnert KD; Augstein P; Zander E; Heinke P; Peterson K; Freyse EJ; Hovorka R; Salzsieder E
    Diabetes Care; 2009 Jun; 32(6):1058-62. PubMed ID: 19244086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin requirement profiles and related factors of insulin pump therapy in patients with type 2 diabetes.
    Yang X; Deng H; Zhang X; Yang D; Yan J; Yao B; Weng J; Xu W
    Sci China Life Sci; 2019 Nov; 62(11):1506-1513. PubMed ID: 31197759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of insulin therapy on non-insulin-dependent diabetics with secondary oral hypoglycemic agent failure.
    Peng YS; Juang JH
    Changgeng Yi Xue Za Zhi; 1998 Sep; 21(3):271-6. PubMed ID: 9849007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing oral medication adherence among patients with type 2 diabetes mellitus treated with polytherapy in a developed Asian community: a cross-sectional study.
    Lee CS; Tan JHM; Sankari U; Koh YLE; Tan NC
    BMJ Open; 2017 Sep; 7(9):e016317. PubMed ID: 28912194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postprandial glucose monitoring further improved glycemia, lipids, and weight in persons with type 2 diabetes mellitus who had already reached hemoglobin A1c goal.
    Zhang DA; Katznelson L; Li M
    J Diabetes Sci Technol; 2012 Mar; 6(2):289-93. PubMed ID: 22538137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal changes in glycaemic thresholds for treatment intensification in type 2 diabetes in an urban Australian setting: the Fremantle Diabetes Study.
    Davis TME; Chubb SAP; Curtis BH; Barraclough H; Davis WA
    Intern Med J; 2018 Oct; 48(10):1215-1221. PubMed ID: 29230931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycemic Control and Pregnancy Outcomes in Women with Type 2 Diabetes Treated with Oral Hypoglycemic Agents.
    Feghali MN; Caritis SN; Catov JM; Scifres CM
    Am J Perinatol; 2017 Jun; 34(7):697-704. PubMed ID: 27984840
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.